Status: OWNED (200 shares, ₹1.04L invested, ~7% of portfolio)
Quality Score: 16/25 (Grade B: Moderate Conviction)
Last Updated: 2026-03-20 | Data Source: Screener.in + Groww MCP
Entry: ₹518.95 avg | CMP: ₹526 | P&L: +1.41%
One-line thesis: India's largest solar pump manufacturer riding PM-KUSUM's ₹34,000 Cr government scheme — TAM-anchored DCF confirms the stock is fairly valued at CMP ₹526, not undervalued; risk/reward is asymmetric (bear -45%, bull +29%), making this a HOLD with a disciplined re-entry level below ₹420.
Action: HOLD — do NOT add at current prices. Better entry: ₹380–₹420.
| Level | Price | Trigger |
|---|---|---|
| Buy / Add | ₹380 – ₹420 | Between bear DCF floor ₹290 and base ₹492 — only add when margin of safety exists; scheme slowdown or margin compression creates this opportunity |
| Hold | ₹420 – ₹580 | Current range (CMP ₹526) — scheme disbursing, thesis intact, but market has already priced the base scenario |
| Sell / Exit | Above ₹700 | Approaching bull DCF ₹677; OR at fundamental triggers below |
Why now (Mar 2026): DCF base case ₹492 vs CMP ₹526 = stock is within 7% of fair value. This is fundamentally different from KERNEX (+66% to base) or EPACKPEB (+46% to base) — the market has already priced the PM-KUSUM acceleration. TTM OPM compression (24% → 20%) signals margin pressure from competitive tenders. The scheme has 7+ years of runway, but runway alone does not create a margin of safety at current prices.
Manufacturer of pumps, motors, and solar pump controllers. Primary revenue engine: PM-KUSUM scheme — Government of India's ₹34,000 Cr programme to solarize 35 lakh agricultural pumps across India, replacing diesel-powered pumps with solar-powered ones. Shakti is India's largest solar pump manufacturer and a key empanelled vendor with state nodal agencies under MNRE.
Secondary revenue streams: industrial pumps, domestic residential pumps, and export markets (growing but currently ~25-30% of revenue combined). Management direction is to grow non-scheme revenue to 40%+ by FY28.
The thesis in one paragraph: Government scheme creates guaranteed order flow for empanelled vendors. Solar-over-diesel conversion is practically irreversible — energy cost savings of 80-90% make farmers unwilling to revert. ROCE of 55% demonstrates exceptional capital efficiency. The scheme has deployed only ~5 lakh of 35 lakh target pumps (~14% complete), leaving 30 lakh pumps remaining. At Shakti's ~40% market share, that is ₹18,000 Cr of remaining TAM — roughly 7+ years of revenue at the current ₹2,500 Cr/yr run-rate.
The key risk in one sentence: PM-KUSUM disbursement pace is entirely government-controlled; FY23 showed revenue can drop 18% in a single year when scheme slows, and the stock is currently priced for the base scenario not the bear scenario.
| Dimension | Score (1-5) | Notes |
|---|---|---|
| MOAT | 2 | Pumps are a competitive product category. No pricing power beyond government tender wins. Moat is MNRE empanelment + state nodal agency relationships + manufacturing scale — not product differentiation. A new large player obtaining MNRE empanelment (2-3 year process) would immediately compress Shakti's scheme share. |
| Management | 3 | Promoter 50.34%, declining from 56% over 3 years — a concern, not a crisis, but worth monitoring. ROCE 55% and ROE 43% demonstrate excellent capital allocation. Management is building non-scheme diversification (exports, industrial) which is the right long-term move. |
| Financials | 4 | ROE 42.6%, ROCE 55.3% — outstanding. Revenue 3Y CAGR ~29%. FY25 OPM 24%. TTM margin compression to 20% needs watching. Debtor days of 152 are structurally high (government receivables = slow collection) but manageable given D/E is low. |
| Growth Runway | 4 | PM-KUSUM: 30 lakh pumps remaining × ₹1.5L ASP × 40% share = ₹18,000 Cr TAM remaining. Government has committed ₹34,000 Cr to the scheme with ₹27,000–29,000 Cr still undisbursed. 7+ years of scheme runway at current revenue pace. Non-scheme diversification adds optionality. |
| Valuation | 3 | P/E 19.7x TTM, P/B 3.98x. DCF base case ₹492 vs CMP ₹526 = fairly valued. Reasonable multiples for a 55% ROCE business, but scheme dependency caps the premium. Market has priced base scenario — upside requires bull case to materialise. |
| Total | 16/25 | Grade B: Moderate Conviction |
| Year | Revenue (₹Cr) | PAT (₹Cr) | EPS (₹) | OPM% |
|---|---|---|---|---|
| FY22 | 1,179 | 65 | ₹5.88 | — |
| FY23 | 968 | 24 | ₹2.19 | — |
| FY24 | 1,371 | 142 | ₹11.79 | — |
| FY25 | 2,516 | 408 | ₹33.97 | 24% |
| TTM | 2,505 | 329 | ₹27.15 | 20% |
What the history tells you: FY22-23 is the bear case in action — when scheme disbursements slowed, revenue fell 18% and profit collapsed 63% (₹65 Cr → ₹24 Cr). FY24-25 is the bull case in action — when the scheme accelerated, revenue doubled in two years and PAT grew 17x from the FY23 trough. FY25 → TTM OPM compression (24% → 20%) suggests competitive tender pressure or input cost creep is already beginning.
5Y Revenue CAGR: ~29% | 5Y Profit CAGR: ~99%
Note: The 99% profit CAGR is distorted by the ₹24 Cr FY23 base — it is not a reliable forward indicator. Use TTM PAT ₹329 Cr as the conservative base.
| Quarter | Revenue (₹Cr) | OPM% | EPS (₹) |
|---|---|---|---|
| Q1 FY25 | 665 | 25% | ₹9.17 |
| Q4 FY24 | 649 | 24% | ₹8.66 |
| Q3 FY25 | 622 | 23% | ₹8.06 |
| Q2 FY25 | 666 | 20% | ₹7.35 |
Margins trending downward quarter-over-quarter within FY25. TTM OPM 20% vs FY25 peak 24% suggests the compression is real, not seasonal.
| Ratio | Value | Commentary |
|---|---|---|
| D/E | Low | Manageable — not a concern |
| ROE | 42.6% | Exceptional. Above cost of equity by a wide margin. |
| ROCE | 55.3% | Among the highest in the portfolio. Every ₹1 of capital generates ₹0.55 of operating profit. |
| Debtor Days | 152 | Structurally elevated — government receivables move slowly. FCF is significantly below PAT. This is the permanent working capital drag. |
| Promoter | 50.34% | Declining from 56% over 3 years. ~2% per year. At this pace, crosses 45% in ~2.5 years — watch. |
| P/E (TTM) | 19.7x | Reasonable for the ROCE, expensive relative to scheme dependency risk. |
| P/B | 3.98x | BV/share ≈ ₹132. Market implying sustained ROE above cost of equity — which is justified given 43% ROE. |
This is the central risk that shapes every other assumption in the model.
PM-KUSUM contributes ~70-75% of Shakti's revenue. The scheme is not a market — it is a government programme with an annual disbursement budget, state-level implementation agencies, and political continuity requirements. The disbursement pace is set in Delhi, not by Shakti's salesforce.
FY23 is the permanent reference point. Revenue fell from ₹1,179 Cr (FY22) to ₹968 Cr (FY23) — a decline of 18% — purely because the scheme slowed. This happened without any loss of market share, without any deterioration in Shakti's competitive position, and without any macro shock. The government simply disbursed less. PAT fell from ₹65 Cr to ₹24 Cr (63% drop) because fixed costs don't adjust as fast as revenue.
What protects downside: The government has committed ₹34,000 Cr to the scheme and has ₹27,000–29,000 Cr undisbursed. Scheme cancellation is politically untenable (solarizing farm pumps = reducing farmer electricity bills = popular policy). Budget allocation for PM-KUSUM has been increasing annually. The bear case is not zero — it is a return to FY22-23 disbursement pace.
Secondary risks:
| Risk | Probability | Impact | Mitigation |
|---|---|---|---|
| PM-KUSUM slows (budget cuts / election cycle) | Medium | High | FY23 proved this happens. Bear case models it at 5-8% revenue growth. |
| New MNRE-empanelled competitor wins scheme share | Low-Medium | High | Empanelment takes 2-3 years. Once empanelled, a large player with lower cost structure could erode Shakti's 40% share to 30-35%. |
| OPM compression from tender price wars | Medium | Medium | Already visible (24% → 20% TTM). In scheme tenders, L1 pricing means competitors push prices down. |
| Promoter selling | Low | Medium | 50.34% → 56% decline over 3 years. Pace is ~2%/year, not alarming, but needs watching. |
| Debtor days exceed 200 | Low-Medium | High | Government payment delays could surge if state finances deteriorate. D > 200 days = FCF crisis. |
The PM-KUSUM TAM anchor:
The government disbursement pace anchor:
The FY23 precedent anchor (bear case):
FY23 is the clearest possible signal of what the bear case looks like: scheme disburses at ₹2,500 Cr/year → Shakti revenue falls to ~₹1,000-1,200 Cr from scheme, ~₹300-400 Cr non-scheme = ₹1,300-1,600 Cr. The bear case for FY26-28 is NOT a collapse to FY23 levels — Shakti is now larger and non-scheme revenues have grown. Bear case = flat-to-low-single-digit growth, not negative growth.
The non-scheme diversification anchor:
Management target: 40%+ non-scheme revenue by FY28 (currently ~25-30%). Industrial pumps and export both carry slightly higher margins than scheme pumps (no tender price pressure). If export and industrial together reach ₹800-1,000 Cr by FY28, the revenue floor becomes more defensible. This is NOT the base assumption — it is the upside optionality in the bull case.
The OPM trajectory anchor:
Scenario Rationale:
| Scenario | Root Assumption | Why This Growth Rate |
|---|---|---|
| Bear | Scheme disbursement returns to FY22-23 pace (₹2,500-3,000 Cr/yr govt outlay) | FY23 showed -18% revenue. Bear FY26 is not a fresh drop — Shakti has a larger non-scheme base now, so bear = flat to +5%, not -18%. Revenue growth anchored to government budget allocation pace, not market demand. |
| Base | Scheme accelerates moderately (₹4,000-5,000 Cr/yr outlay), non-scheme grows at 15-18% | Government committed ₹34,000 Cr total with 7+ years remaining. Budget has been increasing. Non-scheme industrial/export growing on their own merits. This is "scheme disbursing at current pace + non-scheme adding steady contribution." |
| Bull | Scheme fully accelerates (₹5,000-6,000 Cr/yr outlay) + export breakthrough | Export wins in Africa/SE Asia (where solar pump adoption is early), Shakti replicates its MNRE playbook in export markets. Scheme share holds at 40%. Government accelerates disbursement toward 2028 completion target. |
Bear Case (scheme stays slow at FY22-23 pace):
| Year | Revenue (₹Cr) | Growth | OPM | PAT (₹Cr) | ROCE |
|---|---|---|---|---|---|
| FY26E | 2,400 | -4% | 18% | ~290 | ~45% |
| FY27E | 2,520 | +5% | 18% | ~305 | ~45% |
| FY28E | 2,720 | +8% | 19% | ~340 | ~45% |
ROCE remains elevated (~45%) because the business has high asset turns — working capital is stretched (debtor days 152) but fixed capital requirements are low. Bear ROCE is lower than FY25 (55%) because slow revenue growth means higher fixed cost drag.
Base Case (scheme accelerates moderately, non-scheme grows):
| Year | Revenue (₹Cr) | Growth | OPM | PAT (₹Cr) | ROCE |
|---|---|---|---|---|---|
| FY26E | 2,750 | +10% | 20% | ~365 | 50-52% |
| FY27E | 3,300 | +20% | 21% | ~465 | 52-55% |
| FY28E | 4,100 | +24% | 22% | ~600 | 55%+ |
OPM recovery from 20% → 22% anchored to: (1) operating leverage as revenue scales, (2) non-scheme mix shift improving blended margins. Base PAT ₹465 Cr by FY27 at 19.7x P/E = implied price ₹909 — but that is a 3-year forward number, not today's value.
Bull Case (scheme fully accelerates + export breakthrough):
| Year | Revenue (₹Cr) | Growth | OPM | PAT (₹Cr) | ROCE |
|---|---|---|---|---|---|
| FY26E | 3,000 | +20% | 21% | ~420 | 55%+ |
| FY27E | 3,900 | +30% | 22% | ~570 | 55%+ |
| FY28E | 5,200 | +33% | 23% | ~795 | 55%+ |
Bull requires government to accelerate PM-KUSUM disbursement pace meaningfully AND export/industrial to reach ₹1,000+ Cr. Both conditions are individually plausible but jointly uncertain.
Current Price: ₹526
Market Cap: ₹6,365 Cr (526 × 12.1 Cr shares)
Shares Outstanding: 12.1 Cr
Book Value per Share: ₹132 (P/B 3.98x implied)
TTM PAT: ₹329 Cr | EPS TTM: ₹27.15 | P/E TTM: 19.7x
Why we use TTM PAT ₹329 Cr (not FY25 ₹408 Cr) as the DCF base:
FY25 PAT of ₹408 Cr reflected peak OPM (24%) and a very good disbursement year. TTM PAT ₹329 Cr captures the OPM compression already underway (20% TTM vs 24% FY25). Using the higher FY25 number would overstate the starting FCF base and inflate fair values mechanically. Conservative anchoring requires using the more recent, lower number.
Why FCF = 72% of PAT:
Debtor days of 152 means Shakti collects ~5 months after invoicing. For every ₹100 of PAT earned, approximately ₹28 remains trapped in debtors (government receivables). This is a structural, permanent drag — not a temporary working capital swing. As long as PM-KUSUM is >70% of revenue and the government remains a slow payer, FCF will be materially below PAT. The 72% conversion factor is the realistic FCF yield.
Why 12% discount rate:
12% is the India floor (risk-free 7% + 5% equity risk premium). Shakti gets no additional discount despite scheme dependency because: (a) it is already incorporated in the bear/base/bull FCF growth rates, (b) the scheme itself is backed by a ₹34,000 Cr committed outlay, not speculative. However, no premium to 12% is given (unlike a capital-light compounder like an AMC) because the business is scheme-dependent and commodity-exposed.
Base PAT: ₹329 Cr (TTM — conservative vs FY25 ₹408 Cr) | FCF: 72% of PAT (debtor days structural drag)
Discount rate: 12% | Shares: 12.1 Cr
| Scenario | PAT Growth Rates | Rationale | OPM Assumption | Terminal g | FCF% | Fair Value | vs ₹526 |
|---|---|---|---|---|---|---|---|
| Bear | Y1: +2%, Y2: +5%, Y3-5: +8%/yr | FY23 showed disbursement slowdown → -18% revenue. Bear is NOT zero growth — non-scheme base (₹600-700 Cr) provides a floor. Growth anchored to scheme disbursing at FY22-23 pace (~₹2,500 Cr/yr govt outlay). | 18% — competitive tenders compress from TTM 20%; no export margin uplift | 4.5% — government-dependent commodity product; below India nominal GDP because commoditization risk is permanent | 72% | ₹290 | -45% |
| Base | Y1: +10%, Y2: +20%, Y3: +25%, Y4: +20%, Y5: +15% | 30 lakh remaining pumps + 40% Shakti share = ₹18,000 Cr TAM. Government budget committed ₹34,000 Cr. Scheme acceleration (₹4,000-5,000 Cr/yr outlay). Non-scheme growing at 15%. OPM recovering modestly as exports scale. | 20-22% over 5 years — stabilising at TTM level, slight recovery from non-scheme mix shift | 5% — India nominal GDP; scheme is a finite programme so no above-GDP terminal applies beyond the scheme window | 72% | ₹492 | -6% |
| Bull | Y1: +18%, Y2: +30%, Y3: +32%, Y4: +25%, Y5: +18% | Full scheme acceleration (₹5,000-6,000 Cr/yr) + export breakthrough in Africa/SE Asia; Shakti replicates MNRE empanelment strategy in export markets; non-scheme reaches 40% of revenue by FY28. | 21-23% — export business higher-margin (no L1 tender pricing); OPM recovers toward FY25 levels | 5.5% — marginal above-GDP if export business creates a durable non-scheme growth engine | 72% | ₹677 | +29% |
Key insight — Risk/Reward is asymmetric and unfavorable at CMP:
| Fair Value | ₹290 | ₹492 | ₹677 |
|---|---|---|---|
| vs CMP ₹526 | -45% | -6% | +29% |
| Probability weight (rough) | 25% | 55% | 20% |
| Weighted contribution | -₹59 | -₹19 | +₹30 |
| Probability-weighted outcome | ≈ -₹48 (-9% from CMP) |
The probability-weighted DCF implies a slight downside from CMP. This is not a stock to add at ₹526.
What makes SHAKTIPUMP different from KERNEX and EPACKPEB:
This is the fundamental conclusion: SHAKTIPUMP is not cheap. The PM-KUSUM opportunity is well-known, well-covered, and already reflected in the price. Buying here is paying full price for the base case with significant downside if the scheme slows.
Book Value per Share: ₹132 | Cost of Equity (Ke): 12% | Formula: P/B = (ROE - g) / (Ke - g)
| Scenario | Sustainable ROE | Long-term g | Justified P/B | Fair Value | vs ₹526 |
|---|---|---|---|---|---|
| Bear | 30% (ROE compresses as scheme slows; WC drag weighs on equity returns; competition in scheme tenders) | 5% | (0.30-0.05)/(0.12-0.05) = 3.57x | ₹471 | -10% |
| Base | 42% (current ROE broadly maintained; scheme disbursing + non-scheme scaling) | 6% | (0.42-0.06)/(0.12-0.06) = 6.00x | ₹792 | +51% |
| Bull | 50% (ROE improves as non-scheme/export mix increases; operating leverage at scale) | 7% | (0.50-0.07)/(0.12-0.07) = 8.60x | ₹1,135 | +116% |
Implied ROE at CMP: At P/B 3.98x (₹526 ÷ ₹132), and assuming g=6%:
Implied ROE = 3.98 × (0.12 - 0.06) + 0.06 = 3.98 × 0.06 + 0.06 = 0.239 + 0.06 = ~30%
The market is pricing in a decline from current ROE 42.6% to a sustainable ROE of ~30%. This is a reasonable skepticism for a scheme-dependent business — if disbursements slow, ROE will compress. The P/B-ROE model says that at 42% sustainable ROE, fair value is ₹792 — but whether Shakti can sustain 42% ROE is the entire question.
| Base fair value | ₹492 | ₹792 |
|---|---|---|
| vs CMP ₹526 | -6% | +51% |
| Bear fair value | ₹290 | ₹471 |
| vs CMP ₹526 | -45% | -10% |
The models diverge sharply at the base — and this divergence is the insight:
DCF says fairly valued; P/B-ROE says +51% upside. The gap is entirely explained by the ROE sustainability question:
Which model to weight more heavily for SHAKTIPUMP:
Follow the valuation framework: for capital-dependent manufacturers with government receivables and scheme concentration, weight DCF more heavily. P/B-ROE assumes steady-state returns; DCF captures the disbursement cycle dynamics. The P/B-ROE base case is the optimistic scenario, not the central estimate.
Verdict: DCF base ₹492 is the right anchor. CMP ₹526 is within 7% of fair value. This is a HOLD, not a BUY.
At CMP ₹526, the market is pricing approximately 10-12% annual PAT growth for 5 years. This is exactly the base case. For the stock to outperform from here, the bull scenario (18-33% annual growth from PM-KUSUM acceleration + exports) must materialise AND the market must re-rate the terminal multiple. That is a high bar at current prices.
| Company | Nature | Positioning |
|---|---|---|
| KSB Pumps | German MNC, India-listed | Premium industrial pumps; very limited solar/agricultural exposure. Competes in industrial segment only, not in PM-KUSUM scheme tenders. Higher margins, lower growth. |
| Kirloskar Brothers | Diversified pumps (large) | Broad pump portfolio but no meaningful solar pump / PM-KUSUM focus. Different customer base. |
| CRI Pumps | Private; not listed | Competes in agricultural and industrial pumps; some solar pump presence. No MNRE scale to match Shakti. |
| Competitor | Threat Level | Notes |
|---|---|---|
| Grundfos | Low-Medium | Global pump major; present in India but premium positioning. Limited rural scheme penetration. |
| Wilo (Germany) | Low | Premium industrial focus; not a PM-KUSUM tender competitor at scale. |
| Local assemblers | Medium | Dozens of small assemblers with imported components. Can undercut on price in L1 tenders but lack MNRE empanelment for all state nodal agencies and lack after-sales service networks. |
| New MNRE entrant (hypothetical) | High if materialises | Any large player (Kirloskar, L&T, etc.) that invests 2-3 years in obtaining MNRE empanelment and builds a rural service network could take 10-15% share from Shakti. This is the single largest structural risk. |
1. MNRE empanelment breadth: Approved vendor with state nodal agencies across 20+ states. Getting empanelled in each state takes 1-3 years and requires demonstration plants, after-sales commitments, and local inventory. Replicating this network is not a 12-month effort.
2. Manufacturing scale: Producing 5+ lakh pumps/year requires a supply chain and manufacturing operation that most competitors lack. Scale = lower BOM cost = ability to bid lower in L1 tenders while maintaining acceptable margins.
3. Rural service network: A solar pump system (pump + controller + panel + wiring) requires installation support and maintenance in Tier 3/4 districts. Shakti has the installer ecosystem; most competitors do not.
4. Brand trust with state agencies: After years of delivering under the scheme, state nodal agencies know Shakti's track record. Switching to a new vendor for ₹100 Cr+ contracts involves operational risk that procurement officials are reluctant to take.
The vulnerability: These are moats of process and relationships, not technology or IP. A patient, well-capitalised competitor (a Kirloskar Brothers, for instance) could replicate all of this over 3-5 years. This is why the MOAT score is 2/5, not 3 or 4. The moat is real but not durable against a determined large-cap entrant.
| Date | Action | Price | Quantity | Reasoning |
|---|---|---|---|---|
| Mar 2026 (initial) | BUY | ₹518.95 avg | 200 | PM-KUSUM scheme, 55% ROCE, India's largest solar pump player. Entered near fair value — acceptable for a HOLD position. |
SHAKTIPUMP is NOT the portfolio's multi-bagger candidate. The numbers are clear:
The correct positioning for SHAKTIPUMP: It is a high-quality, fairly-valued compounder in a government scheme. Hold it as part of a diversified portfolio. Do not size it up at current prices. Re-rate if non-scheme revenue visibly accelerates and scheme disbursements stay strong — that combination (which has not happened yet) would justify the bull case, not just the base case.
New learnings, commentary, and thesis updates — most recent first.
Full edit history: git log research/SHAKTIPUMP.md